By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Z-drug hypnotic > Eszopiclone

Eszopiclone

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|630 words

What is Eszopiclone?

Eszopiclone is a prescription sleep medication that belongs to a class of drugs called Z-drug hypnotics or nonbenzodiazepine hypnotics. It is primarily used to treat insomnia, particularly difficulty falling asleep and staying asleep throughout the night. Unlike older sleep medications, eszopiclone is designed to help maintain sleep for longer periods while causing less dependency and fewer next-day side effects.

Uses

Eszopiclone is approved and commonly prescribed for several sleep-related conditions:

  • Sleep-onset insomnia: Helps people who have trouble falling asleep initially when going to bed
  • Sleep-maintenance insomnia: Assists those who wake up frequently during the night and have difficulty returning to sleep
  • Early morning awakening: Helps prevent premature awakening and allows for a full night’s rest
  • Short-term sleep disturbances: Used for temporary insomnia caused by stress, travel, or schedule changes
  • Chronic insomnia: May be prescribed for long-term sleep disorders when other treatments have been ineffective

How it works

Eszopiclone works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that promotes relaxation and sleep in the brain. It binds selectively to specific GABA receptor sites, particularly those containing the alpha-1 subunit, which are responsible for sedation and sleep induction. This selective binding helps produce sleep-promoting effects while minimizing some of the side effects associated with older sleep medications like benzodiazepines.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Unpleasant metallic taste in the mouth
  • Dry mouth
  • Drowsiness or grogginess the next day
  • Dizziness
  • Headache
  • Cold or flu-like symptoms
  • Nausea
  • Nervousness or anxiety

Serious side effects to watch for:

  • Complex sleep behaviors (sleep-driving, sleep-eating, sleep-walking)
  • Severe allergic reactions including swelling of face, lips, or throat
  • Depression or suicidal thoughts
  • Severe confusion or memory problems
  • Abnormal behavior or agitation

Warnings and precautions

  • Pregnancy and breastfeeding: Should be avoided during pregnancy and breastfeeding as it may harm the developing baby and passes into breast milk
  • Liver impairment: Patients with severe liver disease should avoid eszopiclone, and those with mild to moderate liver problems may need dose adjustments
  • Elderly patients: Older adults are more sensitive to the effects and may experience increased risk of falls, confusion, and next-day impairment
  • Mental health conditions: Can worsen depression or suicidal thoughts, and should be used cautiously in patients with a history of substance abuse
  • Respiratory conditions: May cause breathing problems in patients with severe lung disease or sleep apnea

Interactions

  • CYP3A4 inhibitors (ketoconazole, clarithromycin): Can increase eszopiclone levels, leading to enhanced sedation and side effects
  • Alcohol: Significantly increases drowsiness and risk of dangerous sleep behaviors; should never be combined
  • Opioid pain medications: Can cause severe respiratory depression and excessive sedation when used together
  • Benzodiazepines: Combination increases risk of severe sedation, breathing problems, and overdose
  • Rifampin: May decrease eszopiclone effectiveness by increasing its metabolism
  • CNS depressants (antihistamines, muscle relaxants): Can enhance sedative effects and increase fall risk
  • St. John’s Wort: May reduce eszopiclone’s effectiveness by increasing drug metabolism
  • Grapefruit juice: Can increase eszopiclone blood levels and enhance side effects

Check interactions with the GMJ Interaction Checker

Dosage

The typical starting dose for adults is 1 mg taken immediately before bedtime, with at least 7-8 hours available for sleep. The dose may be increased to 2 mg or 3 mg if needed, based on effectiveness and tolerability. Elderly patients and those with liver impairment typically start with 1 mg and should not exceed 2 mg. The medication should be taken on an empty stomach or with a light meal, as heavy or high-fat meals can delay its effectiveness. Dosage should always be determined and monitored by a healthcare provider, and the lowest effective dose should be used to minimize the risk of dependence and side effects.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Eszopiclone." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/eszopiclone/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Magnesium’s hidden role in insulin signalling: why the mineral matters for glucose control

Magnesium acts as a critical molecular switch in insulin signalling. New analysis…

Why the same bread raises blood sugar differently in different people

Researchers at the Weizmann Institute found that identical carbohydrate meals produce glucose…

Vitamin D dose response is not linear: Why shelf-picked supplements may not work as expected

Vitamin D supplements do not work the same way for everyone. Research…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Zopiclone

By
Prof. Giorgi Pkhakadze
02/06/2026

Zolpidem

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up